Maternal, fetal and neonatal diagnosis of congenital human cytomegalovirus infection

Expert Opinion on Medical Diagnostics

Volumn 2, Issue 5, 2008, Pages 547-563

  Revello, Maria Grazia ^a   Gerna, Giuseppe ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Diagnosis; Fetus; Human cytomegalovirus; Infection; Newborn; Pregnant woman

Indexed keywords

BIOLOGICAL MARKER; CYTOMEGALOVIRUS VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY;

AMNIOCENTESIS; AMNION FLUID; AMNION FLUID ANALYSIS; ANTIBODY DETECTION; ANTIBODY SCREENING; BLOOD SAMPLING; CHEMOLUMINESCENCE; CLINICAL FEATURE; CONGENITAL INFECTION; CORDOCENTESIS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS BLOOD; HUMAN; IMMUNOBLOTTING; INTRAUTERINE INFECTION; LABORATORY TEST; MICROPARTICLE ENZYME IMMUNOASSAY; MOTHER; NEWBORN INFECTION; POLYMERASE CHAIN REACTION; PREDICTION AND FORECASTING; PREGNANCY; PRENATAL DIAGNOSIS; PRIMARY INFECTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; ULTRASOUND; VIROLOGY;

EID: 77953428902     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2.5.547     Document Type: Review

References (91)

1. Weller TH, Macaulay JC, Craig JM, Wirth P. Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med 1957;94:4-12
2. Institute of Medicine Committee. Cytomegalovirus. In: Stratton KR, Durch JS, Lawrence RS, editors, Vaccine for the 21st century; Washington DC: The National Academies Press; 2000. p. 165-171
3. Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663-7 •• Maternal antibody to CMV before conception provides substantial protection against congenital infection, while primary infection in pregnancy is associated with more severe sequelae.
4. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253-276 (Pubitemid 47066638)
5. Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005;5:70 (Pubitemid 41185343)
6. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002;15:680-715 •• This is a comprehensive review of the most sensitive assays for diagnosis of primary HCMV infection in the mother, the fetus (fetal blood and amniotic fluid) and the newborn infant (blood and urine). Several more controversial issues, such as the impact of correct counseling on decision-making by the couple, are discussed.
7. Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to the fetus and clinical outcome. JAMA 1986;256:1904-1908 (Pubitemid 16033392)
8. Pass RF, Fowler KB, Boppana SB, et al. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006;35:216-220 (Pubitemid 43053403)
9. Williamson DW, Demmler GJ, Percy AK, Catlin FI. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 1992;90:862-866
10. Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350-62 • Treatment of pregnant women with CMV-specific hyperimmune globulin is safe, and may be effective in both treatment and prevention of congenital CMV infection.
11. Jacquemard F, Yamamoto M, Costa JM, et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007;114:1113-21 • Maternal oral administration of valaciclovir leads to therapeutic concentrations in the maternal and fetal compartments, with a decrease of viral load in fetal blood. (Pubitemid 47247017)
12. Revello MG, Percivalle E, Zannino M, et al. Development and evaluation of a capture ELISA for IgM determination to the human cytomegalovirus major DNA binding protein. J Virol Methods 1991;35:315-329
13. Revello MG, Zavattoni M, Furione M, et al. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infection. J Infect Dis 2002;186:553-557 (Pubitemid 34876266)
14. Thomas HI, Morgan-Capner P, Roberts A, Hesketh L. Persistent rubella-specific IgM reactivity in the absence of recent primary rubella and rubella reinfection. J Med Virol 1992;36:188-192
15. Nielsen CM, Hansen K, Andersen HMK, et al. An enzyme labeled nuclear antigen immunoassay for detection of IgM antibodies in human serum: specific and non-specific reactions. J Med Virol 1987;22:67-76 (Pubitemid 17077600)
16. Just-Nübling G, Korn S, Ludwig B, et al. Primary cytomegalovirus infection in an outpatient setting-laboratory markers and clinical aspects. Infection 2003;31:318-323 (Pubitemid 37260366)
17. Miedjie Deyi Y, Goubau P, Bodéus M. False-positive IgM antibody for cytomegalovirus in patients with acute Epstein-Barr virus infection. Eur J Clin Microbiol Infect Dis 2000;19:557-560 (Pubitemid 30612002)
18. Pass RF, Griffiths PD, August AM. Antibody response to cytomegalovirus after renal transplantation: Comparison of patients with primary and recurrent infection. J Infect Dis 1983;161:454-461 (Pubitemid 13190222)
19. Engelhard D, Weinberg M, Or R, et al. Immunoglobulins A, G, and M to cytomegalovirus during recurrent infection in recipients of allogeneic bone marrow tranplantation. J Infect Dis 1991;163:628-630
20. Revello MG, Lilleri D, Zavattoni M, et al. Human cytomegalovirus immediate-early messenger RNA in blood of pregnant women with primary infection and of congenitally infected newborns. J Infect Dis 2001;184:1078-1081 (Pubitemid 32955128)
21. Jahn G, Scholl BC, Traupe B, Fleckenstein B. The two major phosphoprotein (pp65 and pp150) of human cytomegalovirus and their antigenic properties. J Gen Virol 1987;68:1327-1337 (Pubitemid 17055257)
22. Kraat YJ, Stals FS, Christiaans MHL, et al. IgM antibody detection for 38 (ppUL80a) and 150 (ppUL32) kDa proteins by immunoblotting: the earliest parameter for acute cytomegalovirus infection in renal transplant recipients. J Med Virol 1996;48:289-294 (Pubitemid 26101553)
23. Ripalti A, Dal Monte P, Boccuni MC, et al. Prokaryotic expression of a large fragment of the most antigenic cytomegalovirus DNA-binding protein (ppUL44) and its reactivity with human antibodies. J Virol Methods 1994;46:39-50 (Pubitemid 24063609)
24. Vornhagen R, Hinderer W, Sonneborg HH, et al. The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection. J Clin Microbiol 1995;33:1927-1930
25. Greijer AS, Van de Crommert JM, Stevens SJ, Middeldorp JM. Molecular fine-specificity analysis of the antibody responses to human cytomegalovirus and design of novel synthetic-peptide-based serodiagnostic assays. J Clin Microbiol 1999;37:179-188 (Pubitemid 29004203)
26. Landini MP, Lazzarotto T, Maine GT, et al. Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassays. J Clin Microbiol 1995;33:2535-2542
27. Vorhagen R, Plachter B, Hinderer W, et al. Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J Clin Microbiol 1994;32:981-986 (Pubitemid 24100073)
28. Maine GT, Stricker R, Schuler M, et al. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. J Clin Microbiol 2000;38:1476-81 • The new assay based on the use of portions of four CMV proteins (pp150, pp52, pp65 and pp38) is reported to be very sensitive for detection of CMV IgM during primary CMV infection. (Pubitemid 30216675)
29. Lazzarotto T, Galli C, Pulvirenti R, et al. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin Diagn Lab Immunol 2001;8:196-198 (Pubitemid 32065677)
30. Munro SC, Hall B, Whybin LR, et al. Diagnosis and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol 2005;43:4713-4718 (Pubitemid 41298268)
31. Genser B, Trushnig-Wilders M, Stünzner D, et al. Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus- specific IgM antibodies in the absence of a commercially available gold standard. Clin Chem Lab Med 2001;39:62-70 (Pubitemid 32186282)
32. Guerra B, Simonazzi G, Banfi A, et al. Impact of diagnostic and confirmatory tests and prenatal counselling on the rate of pregnancy termination among women with positive immunoglobulin M antibody titers. Am J Obstet Gynecol 2007;221:e-1-6 (Pubitemid 46341184)
33. Revello MG, Gerna G. Diagnosis and implications of human cytomegalovirus infection in pregnancy. Fet Matern Med Rev 1999;11:117-134 (Pubitemid 30671123)
34. Chawla A, Murphy G, Donnelly C, et al. Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol 2007;45:415-420 (Pubitemid 46272055)
35. Blackburn NK, Besselaer TG, Schoub BD, O'Connell KF. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J Med Virol 1991;33:6-9
36. Bodeus M, Feyder S, Goubau P. Avidity of IgG antibodies distinguishes primary from non primary cytomegalovirus infection in pregnant women. Clin Diagn Virol 1998;9:9-16 (Pubitemid 28153242)
37. Grangeot-Keros L, Mayaux MJ, Lebon P, et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 1997;175:944-946 (Pubitemid 27142973)
38. Lazzarotto T, Spezzacatena P, Varani S, et al. Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin Diagn Lab Immunol 1999;6:127-129 (Pubitemid 29035651)
39. Bodéus M, Van Ranst M, Bernard P, et al. Anticytomegalovirus IgG avidity in pregnancy: a 2-year prospective study. Fetal Diagn Ther 2002;17:362-366 (Pubitemid 36160159)
40. Lazzarotto T, Varani S, Spezzacatena P, et al. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol 2000;13:137-141 (Pubitemid 30151787)
41. Prince HE, Leber AL. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels. Clin Diagn Lab Immunol 2002;9:824-827 (Pubitemid 34773885)
42. Revello MG, Gorini G, Gerna G. Clinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin G avidity to human cytomegalovirus. Clin Diagn Lab Immunol 2004;11:801-805 (Pubitemid 38944011)
43. Baccard-Longere M, Freymuth F, Cointe D, et al. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin Diagn lab Immunol 2001;8:429-431 (Pubitemid 32217078)
44. Bodéus M, Beulné D, Goubau P. Ability of three IgG-avidity assays to exclude recent cytomegalovirus infection. Eur J Clin Microbiol Infect Dis 2001;20:248-252 (Pubitemid 32477242)
45. Dangel V, Bäder U, Enders G. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples. J Clin Virol 2006;35:303-309 (Pubitemid 43188977)
46. Macé M, Sissoef L, Rudent A, Grangeot-Keros L. A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women. Prenat Diagn 2004;24:861-863 (Pubitemid 39576798)
47. Stalder H, Ehresenberger A. Microneutralization of cytomegalovirus. J Infect Dis 1980;142:102-105 (Pubitemid 10035154)
48. Eggers M, Metzger C, Enders G. Differentiation between acute primary and recurrent human cytomegalovirus infection in pregnancy, using a microneutralization assay. J Med Virol 1998;56:352-358 (Pubitemid 28516604)
49. Eggers M, Bäder U, Enders G. Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol 2000;60:324-30 • The combined application of the microneutralization and avidity assays is reported to be useful for diagnosis of a recent primary infection during the second trimester of pregnancy. (Pubitemid 30054287)
50. Gerna G, Sarasini A, Patrone M, et al. Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial-epithelial but not fibroblast cells early during primary infection. J Gen Virol 2008;89:853-65 •• Primary HCMV infection elicits very early neutralizing antibody capable of blocking HCMV infection of endothelial/epithelial, but not fibroblast cells. This implies a change in the assessed procedure for neutralizing antibody determination.
51. Hahn G, Revello MG, Patrone M, et al. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 2004;78:10023-33 •• UL131, UL130 and UL128 gene products are essential for HCMV infection of endothelial/epithelial cells and virus transfer to leukocytes, but are dispensable for infection of fibroblasts. (Pubitemid 39187120)
52. Gerna G, Sarasini A, Genini E, et al. Prediction of endothelial cell tropism of human cytomegalovirus strains. J Clin Virol 2006;35:470-473 (Pubitemid 43324849)
53. Schoppel K, Kropff B, Schmidt C, et al. The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies. J Infect Dis 1997;175:238-245 (Pubitemid 27086155)
54. Sipewa MJ, Goubau P, Bodéus M. Evaluation of a cytomegalovirus glycoprotein B recombinant enzyme immunoassay to discriminate between a recent and a past infection. J Clin Microbiol 2002;40:3689-3693
55. Revello MG, Zavattoni M, Sarasini A, et al. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis 1998;177:1170-5 • HCMV may be detected in blood for several months after onset of primary infection, but never in HCMV-immune subjects with recurrent infection. (Pubitemid 28194253)
56. Zanghellini F, Boppana SB, Emery VC, et al. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 1999;180:702-707 (Pubitemid 29411355)
57. Lazzarotto T, Gabrielli L, Lanari M, et al. Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection. Hum Immunol 2004;65:410-415 (Pubitemid 38686764)
58. Revello MG, Lilleri D, Zavattoni M, et al. Lymphoproliferative response in primary human cytomegalovirus infection (HCMV) infection is delayed in HCMV transmitter mothers. J Infect Dis 2006;193:269-76 • A dissociation between an early intracellular cytokine production and a delayed lymphoproliferative response in primary HCMV infection is reported. Such a delay is significantly greater in transmitter versus non-transmitter mothers.
59. Wreghitt TG, Teare EL, Sule O, et al. Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 2003;37:1603-1606 (Pubitemid 37549944)
60. Reynes J, Jambon F. Acquired cytomegalovirus infections in immunocompetent adults. Presse Med 1988;27:1774-1779
61. Revello MG, Gerna G. Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J Clin Virol 2004;29:71-83 (Pubitemid 38121576)
62. Daiminger A, Bäder U, Enders G. Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. BJOG 2005;112:166-172 (Pubitemid 40188244)
63. Lilleri D, Fornara C, Furione M, et al. Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. J Infect Dis 2007;195:1062-1070 (Pubitemid 46452113)
64. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low speed centrifugation and monoclonal antibody to an early antigen. J Clin Microbiol 1984;19:917-9 • The shell vial assay reported in this publication has become the test of choice for rapid HCMV detection in clinical samples. (Pubitemid 14105054)
65. Gerna G, Baldanti, Percivalle E, et al. Early dentification of human cytomegalovirus strains by the shell vial assay is driven by amino acid substitution in UL123 E1 gene product. J Clin Microbiol 2003;41:4494-4495 (Pubitemid 37099744)
66. Liesnard C, Donner C, Brancart F, et al. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 2000;95:881-8 • A reliable prenatal diagnosis of congenital CMV infection can be made after 21 weeks' pregnancy, following a 7-week interval between diagnosis of maternal infection and the antenatal procedure.
67. Enders G, Bäder U, Lindemann L, et al. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001;21:362-77 • Normal ultrasound findings of infected fetuses at 22-23 weeks' gestation does not exclude the birth of a severely damaged child.
68. Revello MG, Lilleri D, Zavattoni M, et al. Prenatal diagnosis of congenital human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based amplification assay. J Clin Microbiol 2003;41:1772-1774 (Pubitemid 36428140)
69. Gouarin S, Gault E, Vabret A, et al. Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol 2002;40:1767-1772 (Pubitemid 34493156)
70. Revello MG, Sarasini A, Zavattoni M, et al. Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction. J Med Virol 1998;56:99-103 (Pubitemid 28380437)
71. Revello MG, Furione M, Zavattoni M, et al. Human cytomegalovirus (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus. J Infect Dis 2008;197:593-6 • Presence of HCMV DNA in blood at amniocentesis does not seem to be a major risk factor for virus transmission to the fetus. However, it is suggested that invasive diagnostic procedures be performed in the absence of HCMV maternal DNAemia. (Pubitemid 351321538)
72. Donner C, Liesnard C, Content J, et al. Prenatal diagnosis of 52 pregnancies at risk for congenital cytomegalovirus infection. Obstet Gynecol 1993;82:481-486 (Pubitemid 23278242)
73. Lamy ME, Mulongo KN, Gadisseaux JF, et al. Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol 1992;166:91-94
74. Revello MG, Zavattoni M, Sarasini A, et al. Prenatal diagnostic and prognostic value of human cytomegalovirus load and IgM antibody response in blood of congenitally infected fetuses. J Infect Dis 1999;180:1320-3 • A correlation is documented between viral load in fetal blood and presence/absence of abnormal ultrasound/biochemical findings. (Pubitemid 30070220)
75. Ahmad-Zalmai A, Vial Y, Fawer C-L, et al. Prenatal diagnosis of congenital cytomegalovirus infection. Obstet Gynecol 2001;97:443-448 (Pubitemid 32184710)
76. Revello MG, Zavattoni M, Furiore M, et al. Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses. J Clin Microbiol 1999;37:3350-3352 (Pubitemid 29455232)
77. Nedelec O, Bellagra N, Devisme L, et al. Congenital human cytomegalovirus infection: value of human cytomegalovirus DNA quantification in amniotic fluid. Ann Biol Clin 2002;60:201-207 (Pubitemid 34289097)
78. Guerra B, Lazzarotto T, Quarta S, et al. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2000;183:476-482 (Pubitemid 30651101)
79. Gerna G, Zavattoni M, Baldanti F, et al. Human cytomegalovirus leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection. Transplantation 1998;65:1378-1385 (Pubitemid 28283102)
80. Stagno S. Cytomegalovirus. In: Remington JS, Klein JO, editors, Infectious diseases of the fetus and newborn infant. WB Saunders Co.: Philadelphia, PA; 2001. p. 389-424
81. Demmler GJ, Buffone GJ, Schimbor CM, May RA. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis 1988;158:1177-1184 (Pubitemid 19023280)
82. Nozawa N, Koyano S, Yamamoto Y, et al. Real-time PCR assay using specimens on filter disks as a template for detection of cytomegalovirus in urine. J Clin Microbiol 2007;45:1305-1307 (Pubitemid 46626502)
83. Balcarek KB, Warren W, Smith RJ, et al. Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva. J Infect Dis 1993;167:1433-1436 (Pubitemid 23146198)
84. Yamamoto AY, Mussi-Pinhata MM, Marin LJ, et al. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection? J Clin Virol 2006;36:228-230
85. Nelson CT, Istas AS, Wilkerson MK, Demmler GJ. PCR detection of cytomegalovirus DNA in serum as a diagnostic for congenital cytomegalovirus infection. J Clin Microbiol 1995;33:3317-3318
86. Revello MG, Zavattoni M, Baldanti F, et al. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol 1999;14:57-66 • Determination of viral DNA in blood at birth is a sensitive and specific assay for diagnosis of congenital HCMV infection. HCMV load is significantly higher in infants with symptomatic versus asymptomatic congenital infection. However, virus clearance from blood occurs in both groups. (Pubitemid 29454638)
87. Lanari M, Lazzarotto T, Venturi V, et al. Neonatal cytomegalovirus load and risk of sequelae in symptomatic and asymtpomatic congenitally infected newborns. Pediatrics 2006;117:e76-83 (Pubitemid 46050503)
88. Shibata M, Takano H, Hironaka T, Hirai K. Detection of human cytomegalovirus DNA in dried newborn blood filter paper. J Virol Methods 1994;46:279-285 (Pubitemid 24069387)
89. Barbi M, Binda S, Caroppo S. Diagnosis of congenital CMV infection via dried blood spots. Rev Med Virol 2006;16:385-92 • This is a comprehensive review of the diagnostic value of using dried blood spots for retrospective diagnosis of congenital CMV infection.
90. Barbi M, Mackay W, Binda S, Van Loon A. External quality assessment of CMV-DNA detection on dried blood spots [abstract book]. 11th International CMV and Betaherpes Virus Workshop; 2007 May 13-17; Toulouse, France. p. 222
91. Stagno S, Tinker MK, Elrod C, et al. Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants. J Clin Microbiol 1985;21:930-935 (Pubitemid 15058941)